Treating To Target Of Minimal Disease Activity And Normal Function In Polyarticular Juvenile Idiopathic Arthritis With Adalimumab: Analysis From A Phase 3 Clinical Trial
AuthID
P-00G-4C5
P-00G-4C5
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service